FDA Investigator Nicholas P Diorio

Nicholas P Diorio has inspections in 2 countries as of 13 Nov 2023. Nicholas P Diorio has collaborated with a combined 3356 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
13 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, China
Alan M Barker, Alan M Roberts, Alicia M Mozzachio, Amanda Dinaro, Amanda S Zorn, Ana E Morales, Ana L Kewes, Anastasia M Shields, Anders W Evenson, Andrew J Barrowcliff, Ann Marie Montemurro, Ann Marie Schofield, Anthony R Ronga, Antoinette L Chancey, Arsen Karapetyan, Ashley L Reiber, Audrey Dela Cruz, Barry Cherney, PhD, Bradley J Maunder, Brentley S Collins, Brian D Nicholas, Brian D Nicholson, Brian P Emanuel, Brittani N Franklin, Brittany R Laymon, Bruce H Mccullough, Bruce Mccullough, Bryan L Mcguckin, Carl A Huffman, III, Carrie Ann Plucinski, CDR Ileana Barreto Pettit, Chad E Schmear, Chad J Whitwell, Chad W Rice, Charisse K Green, Charles L Zhou, Chase S Baldwin, Chery Grandinetti, Christina A Miller, Christina V Santos, Christopher D Leach, Clinton J Lott, Clotia Cabbey Mensah, Dariusz Galezowski, David Perkins, Debra I Love, Debra L Boyd Seale, Dell S Moller, Denarvis C Mendenhall, Denise M Digiulio, Dr. S Nar Ali, PhD, Dr. Zhou Chen (nmi), MD PhD, Eboni S Funderburk, Elizabeth L Philpy, Emilie E Kahn, Enrico Joset Mangahis, Enrico Mangahis, Eric M Mueller, PharmD, Eric S Pittman, George Pyramides, Gregory R Dill, Howard Sklamberg, Humera Khan, Jacob G Luts, Jacob G Lutz, James E Roberts, James P Duggan, James W Plucinski, Janae D Price, Jason F Chancey, Jayne E Holcomb, Jeanne J Chiu, Jeanne J Thai, Jeanne M Morris, Jennifer A D'angelo, Jennifer C Johnson, Jeremy W Rotton, Jesse A Vazquez, Jill J Tillman, Jocelyn C Turner, Joel D Hustedt, John M Seale, Joseph A Morkunas, Joseph A Piechocki, Joseph D Cooper, Joshua M Adams, Justin R Hays, Karen Emasley Joseph, Kathleen S Tormey, Kristen E Szenderski, Kshitij A Patkar, Kujtim Sadiku, Latoya A Griffith, Lauren A Crivellone, Lauren N Howard, Laurie A Haxel, Laurimer Kuilan Torres, LCDR Michael H Tollon, Leeterry Moore, Lequita M Mayhew, Leslie D Hintz, Liliya V Bubiy, Lisa Hayka, Lisa Hornback, Lisa M Bellows, Lisa M Feola, Logan M Ebeling, Lorelei S Jarrell, Maksim A Levenchuk, Marcia A Worley, Margaret Torres Vazquez, Marie Bbuen Bigornia, Mark G Peterson, Mark I Kaspar, Michael A Taylor, Michael D Robinson, Michael E Maselli, Michele L Glendenning, Michele Perry Williams, Micmarie Ramos, Mihaly S Ligmond, Nibin Varghese, MS, Nicholas F Lyons, Nicholas J Presto, Nicholas Z Lu, Nicole E Knowlton, Nicole J Clausen, Nicole S Williams, Norman K Starks, Norman L Brown, Pablo Alcantara, Paola S Barnett, Patricia A Mcilroy, Patrick C Klotzbuecher, Patrick E Gainer, Paul L Bellamy, Paula A Trost, Paula P Demichael, Peng Zhou, Philip F Istafanos, DMV, MS, Phung Thien Nguyen, Rachel T Evans, Rafael Padilla, Ralph A Erickson, Rebecca K Olin, Rebecca Rodriguez, Regan T Harp, Regina T Brown, Rita K Kabaso, Robert J Ham, Rona Leblanc, PhD, Rosemary A Sexton, Roshni J Patel, Ross J Grigsby, Russ R Rivy, Russell K Riley, Ruth Smith, Samina S Khan, Sandra A Hughes, Sean P Ryan, Shafiq S Ahadi, Shalonda C Clifford, Shana L Williams, Simone E Pitts, State Agency, Stefen D Mcmillan, Stephen C Mahoney, Stephen D Eich, Sullan, Susan D Yuscius, Susan P Bruederle, Susan Yuscius, Syed N Ali, Tamara Brey, Tara C Alcazar, Tenzin Jangchup, That Q Dang, Thomas J Arista, Todd M Stankewicz, Torrey M Ward, Vaishali J Patel, Veronica Fuentes, MS, Vioela J Caze, William D Sherman, William R Weissinger, Yiyue Zhang (nmi), PhD, Yuanyuan Li, Yvonne E Lozano, Yvonne Lozano

Nicholas P Diorio's Documents

Publish Date Document Type Title
March, 2013 FDA 483 The Compounding Shop, Inc. - Form 483, 2013-03-25
September, 2019 FDA 483 Novum Pharma, LLC - Form 483, 2019-09-24
May, 2013 FDA 483 Rising Pharma Holdings, Inc. - Form 483, 2013-05-03
February, 2010 FDA 483 Microbiological Testing & Consulting, LLC - Form 483, 2010-02-24
September, 2016 FDA 483 Response Sage Products LLC - Form 483R, 2016-09-22
May, 2011 FDA 483 Blistex Inc. - Form 483, 2011-05-10
August, 2015 EIR AbbVie Inc. - EIR, 2015-08-06
June, 2017 EIR Horizon Pharma Inc - US Operations - EIR, 2017-06-06
September, 2011 EIR Medefil, Inc. - EIR, 2011-09-06
January, 2022 FDA 483 American Chinese Medicine Association, Inc - Form 483, 2022-01-20
May, 2013 FDA 483 Response Rising Pharma Holdings, Inc. - Form 483R, 2013-05-03
October, 2009 FDA 483 Sage Products LLC - Form 483, 2009-10-01
December, 2009 FDA 483 Thornton Industries, Inc. - Form 483, 2009-12-18
December, 2015 FDA 483 Isomedix Operations Inc - Form 483, 2015-12-03
March, 2018 FDA 483 Xttrium Laboratories, Inc. - Form 483, 2018-03-15
January, 2023 FDA 483 SGS North America Inc. - Form 483, 2023-01-10
May, 2009 FDA 483 Pharmaceutical Laboratories and Consultants, Inc. - Form 483, 2009-05-21
September, 2010 FDA 483 Blue Island Phenol LLC - Form 483, 2010-09-29
September, 2017 FDA 483 Primrose Candy Company - Form 483, 2017-09-26
September, 2016 FDA 483 Sage Products LLC - Form 483, 2016-09-01
April, 2011 FDA 483 Deibel Laboratories of Illinois, Inc. - Form 483, 2011-04-21
August, 2015 FDA 483 AbbVie Inc. - Form 483, 2015-08-06
December, 2014 FDA 483 J.M. Huber Micropowders, Inc. - Form 483, 2014-12-17
April, 2014 EIR Medline Industries, Inc. - EIR, 2014-04-02
March, 2019 EIR DENTAL TECHNOLOGIES, INC. - EIR, 2019-03-12
March, 2016 EIR Shandong Xinhua Pharmaceutical Company Limited Hutian Branch - EIR, 2016-03-31
December, 2012 EIR Medefil, Inc. - EIR, 2012-12-20
June, 2022 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2022-06-30
August, 2015 FDA 483 Response AbbVie Inc. - Form 483R, 2015-08-06
December, 2010 FDA 483 Rose Laboratories, Inc. - Form 483, 2010-12-01
August, 2014 FDA 483 Vantage Oleochemicals, Inc. - Form 483, 2014-08-21
September, 2016 EIR Sage Products LLC - EIR, 2016-09-01
December, 2012 FDA 483 Medefil, Inc. - Form 483, 2012-12-20
September, 2011 FDA 483 Medefil, Inc. - Form 483, 2011-09-06
September, 2014 EIR Horizon Pharma USA, Inc. - EIR, 2014-09-30
June, 2012 FDA 483 Deibel Laboratories of Illinois, Inc. - Form 483, 2012-06-13
March, 2019 FDA 483 DENTAL TECHNOLOGIES, INC. - Form 483, 2019-03-12
May, 2018 EIR Avatar Corporation - EIR, 2023-10-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more